RAPT Therapeutics Stock (NASDAQ: RAPT) stock price, news, charts, stock research, profile.
You can purchase shares of RAPT Therapeutics (NASDAQ:RAPT) through any online brokerage.
Other companies in RAPT Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Fortress Biotech (NASDAQ:FBIO), HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA) and Gain Therapeutics (NASDAQ:GANX).
RAPT Therapeutics has a consensus price target of $24.40.
The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $1.09 last updated November 20, 2024 at 7:26 PM EST.
There are no upcoming dividends for RAPT Therapeutics.
RAPT Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for RAPT Therapeutics.
RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.